Iovance Biotherapeutics Inc (IOVA)
Who owns Iovance Biotherapeutics Inc (IOVA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 86.9% of the shares are freely tradable; institutional investors hold 67.5%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 6.96 | 31,080,505 | +5.3 | 03/31/2026 |
| Mhr Fund Management Llc | 6.49 | 28,967,103 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 6.09 | 27,207,079 | +13.1 | 12/31/2025 |
| State Street Corp | 3.91 | 17,448,108 | -13.5 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.72 | 16,617,737 | +0.0 | 03/31/2026 |
| Two Sigma Investments LLC | 3.07 | 13,687,433 | +211.2 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 2.62 | 11,700,844 | +0.0 | 03/31/2026 |
| Millennium Management LLC | 2.11 | 9,414,292 | +43.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.79 | 12,478,346 | +0.0 | 04/30/2026 |
| State Street® SPDR® S&P® Biotech ETF | 2.02 | 9,011,058 | -0.6 | 05/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.